PubRank

N Frimodt-Møller

Author PubWeight™ 101.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork. N Engl J Med 2001 2.38
2 Presence of erm gene classes in gram-positive bacteria of animal and human origin in Denmark. FEMS Microbiol Lett 1999 1.93
3 Evaluation of a cefoxitin 30 microg disc on Iso-Sensitest agar for detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2003 1.91
4 Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins. J Infect Dis 1986 1.84
5 Infections with the unusual human pathogens Agrobacterium species and Ochrobactrum anthropi. Clin Infect Dis 1994 1.83
6 Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980-1990. J Infect 1997 1.79
7 Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob Agents Chemother 2000 1.76
8 Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration. Infection 1995 1.61
9 Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 2007 1.61
10 Clinical manifestations and molecular epidemiology of Vibrio vulnificus infections in Denmark. Eur J Clin Microbiol Infect Dis 1996 1.59
11 Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med 1999 1.48
12 In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection 2002 1.48
13 Nosocomial pneumonia in an intensive care unit in a Danish university hospital: incidence, mortality and etiology. Scand J Infect Dis 1992 1.46
14 Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrob Agents Chemother 1995 1.37
15 Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med 1999 1.36
16 Susceptibility of Danish Escherichia coli strains isolated from urinary tract infections and bacteraemia, and distribution of sul genes conferring sulphonamide resistance. J Antimicrob Chemother 2002 1.35
17 [Treatment of upper respiratory tract infections]. Ugeskr Laeger 2000 1.31
18 In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin. J Antimicrob Chemother 2001 1.29
19 Evaluation of cefoxitin 5 and 10 microg discs for the detection of methicillin resistance in staphylococci. J Antimicrob Chemother 2005 1.28
20 Bacteremic Staphylococcus aureus spondylitis. Arch Intern Med 1998 1.28
21 Staphylococcus aureus endocarditis. A review of 119 cases. Arch Intern Med 1986 1.24
22 Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time. Antimicrob Agents Chemother 1997 1.21
23 Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits. Antimicrob Agents Chemother 1998 1.19
24 Genome-wide identification of Streptococcus pneumoniae genes essential for bacterial replication during experimental meningitis. Infect Immun 2010 1.14
25 Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice. J Antimicrob Chemother 2005 1.09
26 Penicillin pharmacodynamics in four experimental pneumococcal infection models. Antimicrob Agents Chemother 2001 1.07
27 Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid. Diagn Microbiol Infect Dis 2001 1.07
28 Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model. Antimicrob Agents Chemother 1997 1.06
29 [Daily single-dose aminoglycoside administration. Therapeutic and economic benefits]. Ugeskr Laeger 1993 1.06
30 Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur J Clin Microbiol Infect Dis 2011 1.03
31 Pretreatment with granulocyte colony-stimulating factor attenuates the inflammatory response but not the bacterial load in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Infect Immun 1999 1.00
32 Treatment of pleural empyema secondary to pneumonia: thoracocentesis regimen versus tube drainage. Thorax 1992 0.99
33 Changing pattern of bone and joint infections due to Staphylococcus aureus: study of cases of bacteremia in Denmark, 1959-1988. Rev Infect Dis 1991 0.98
34 Microbial status and product labelling of 58 original tattoo inks. J Eur Acad Dermatol Venereol 2011 0.98
35 First detection of plasmid-mediated quinolone resistance (qnrA and qnrS) in Escherichia coli strains isolated from humans in Scandinavia. J Antimicrob Chemother 2007 0.97
36 Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates. J Antimicrob Chemother 2001 0.97
37 Antimicrobial resistance in Salmonella enterica subsp. enterica serovar typhimurium from humans and production animals. J Antimicrob Chemother 1997 0.96
38 Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo. Antimicrob Agents Chemother 1998 0.96
39 Antibiotic treatment insufficient for established septic arthritis. Staphylococcus aureus experiments in rabbits. Acta Orthop Scand 1989 0.96
40 Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts. Am J Med 1997 0.95
41 The pneumococcus and the mouse protection test: importance of the lag phase in vivo. Chemotherapy 1983 0.95
42 Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Infect Immun 2000 0.92
43 Antibiotic usage in an intensive care unit in a Danish university hospital. J Antimicrob Chemother 1993 0.91
44 Streptococcus pneumoniae: proteomics of surface proteins for vaccine development. Clin Microbiol Infect 2007 0.91
45 Effect of treatment with methicillin and gentamicin in a new experimental mouse model of foreign body infection. Antimicrob Agents Chemother 1994 0.89
46 Comparison of the effect of cefepime with four cephalosporins against pneumococci with various susceptibilities to penicillin, in vitro and in the mouse peritonitis model. J Antimicrob Chemother 1997 0.89
47 Effects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse model. Antimicrob Agents Chemother 2003 0.89
48 Effect of urine concentration versus tissue concentration of ampicillin and mecillinam on bacterial adherence in the rat bladder. Invest Urol 1981 0.89
49 Staphylococcus aureus meningitis. A review of 104 nationwide, consecutive cases. Arch Intern Med 1993 0.88
50 The pneumococcus and the mouse-protection test: correlation of in vitro and in vivo activity for beta-lactam antibiotics, vancomycin, erythromycin and gentamicin. Acta Pathol Microbiol Immunol Scand B 1987 0.88
51 Prophylactic antibiotics in transurethral prostatectomy. J Urol 1981 0.87
52 Collagen with gentamicin for prophylaxis of postoperative infection. Staphylococcus aureus osteomyelitis studied in rabbits. Acta Orthop Scand 1995 0.87
53 Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally. Clin Exp Immunol 2000 0.87
54 Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints. Clin Microbiol Infect 2007 0.86
55 Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model. J Antimicrob Chemother 1998 0.86
56 Antibiotic prophylaxis in pulmonary surgery: a double-blind study of penicillin versus placebo. Ann Surg 1982 0.85
57 Experimental guinea pig model of dermatophytosis: a simple and useful tool for the evaluation of new diagnostics and antifungals. Med Mycol 2008 0.84
58 Experimental pneumococcus infection in mice: correlation of bactericidal activity in vitro with the effect in vivo for gentamicin, netilmicin and tobramycin. Acta Pathol Microbiol Immunol Scand B 1987 0.84
59 Urinary concentrations and urine ex-vivo effect of mecillinam and sulphamethizole. Clin Microbiol Infect 2004 0.83
60 Corynebacterium xerosis as a cause of community-acquired endocarditis. Eur J Clin Microbiol Infect Dis 1990 0.83
61 Staphylococcus aureus endocarditis in Danish intravenous drug users: high proportion of left-sided endocarditis. Scand J Infect Dis 1995 0.83
62 Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes. Neurobiol Dis 2006 0.82
63 [Demonstration of bacteriuria in elderly hospitalized patients. Comparison between leukocyte and nitrite strips and culture]. Ugeskr Laeger 1992 0.82
64 In-vitro activity of methicillin against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 1985 0.82
65 [Fight against microorganisms--an international concern]. Ugeskr Laeger 1996 0.82
66 Escherichia coli clonal group A causing bacteraemia of urinary tract origin. Clin Microbiol Infect 2012 0.81
67 Aminoglycoside resistance among Danish blood culture isolates of coagulase-negative staphylococci. APMIS 1996 0.81
68 A double-blind, randomized, controlled multicentre study to compare the efficacy of ciprofloxacin with pivampicillin as oral therapy for epididymitis in men over 40 years of age. BJU Int 1999 0.80
69 Antibiotic prophylaxis in vascular reconstructive surgery: a double-blind placebo-controlled study. J Antimicrob Chemother 1986 0.80
70 In vitro activity of six macrolides, clindamycin and tetracycline on Streptococcus pneumoniae with different penicillin susceptibilities. APMIS 1996 0.80
71 Reducing the use of antimicrobial agents in animals and man. J Med Microbiol 2000 0.80
72 Mechanism of aminoglycoside resistance in Danish Staphylococcus aureus strains during the years 1979-1987. APMIS 1991 0.79
73 [Vibrio vulnificus infections in Denmark during the summer of 1994]. Ugeskr Laeger 1996 0.79
74 A study of 47 bacteremic Staphylococcus aureus endocarditis cases: 23 with native valves treated surgically and 24 with prosthetic valves. Scand Cardiovasc J 1997 0.79
75 Staphylococcus aureus bacteremia: a 14-year nationwide study in hematological patients with malignant disease or agranulocytosis. Scand J Infect Dis 1995 0.79
76 Aminoglycoside resistance mechanisms in Enterobacteriaceae and Pseudomonas spp. from two Danish hospitals: correlation with type of aminoglycoside used. APMIS 1996 0.79
77 The antibacterial activity of a siderophore. 1. In vitro activity of deferoxamine alone and in combination with ascorbic acid on Staphylococcus aureus. APMIS 1989 0.79
78 Synergy between a non-neuroleptic thioxanthene stereo-isomer and penicillin in vivo. APMIS 1988 0.79
79 Neonatal colonization with Staphylococcus aureus is not associated with development of atopic dermatitis. Br J Dermatol 2009 0.79
80 Staphylococcus aureus bacteremia in patients with hematological malignancies and/or agranulocytosis. Acta Med Scand 1987 0.79
81 Experience with once daily dosing of gentamicin: considerations regarding dosing and monitoring. Chemotherapy 1997 0.78
82 Antimicrobial-drug use and methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2001 0.78
83 Resistance to dicloxacillin, methicillin and oxacillin in methicillin-susceptible and methicillin-resistant Staphylococcus aureus detected by dilution and diffusion methods. APMIS 1989 0.78
84 The antibacterial activity of a siderophore. 3. The activity of deferoxamine in vitro and its influence on the effect of antibiotics against Escherichia coli, Proteus mirabilis and coagulase-negative staphylococci. APMIS 1994 0.78
85 Detection of clinical vancomycin-resistant enterococci in Denmark by multiplex PCR and sandwich hybridization. APMIS 1999 0.77
86 Relationship between penicillinase production and the in-vitro activity of methicillin, oxacillin, cloxacillin, dicloxacillin, flucloxacillin, and cephalothin against strains of Staphylococcus aureus of different phage patterns and penicillinase activity. J Antimicrob Chemother 1986 0.77
87 Effect of human IgG and fibrinogen on Staphylococcus aureus intraperitoneal infection in mice. Acta Pathol Microbiol Immunol Scand B 1984 0.77
88 The antibacterial activity of a siderophore. 2. The influence of deferoxamine alone and combined with ascorbic acid on the activity of antibiotics against Staphylococcus aureus. APMIS 1991 0.77
89 Killing curve activity of ciprofloxacin is comparable to synergistic effect of beta-lactam-tobramycin combinations against Haemophilus species endocarditis strains. APMIS 1992 0.77
90 Fighting MRSA in hospitals: time to restrict the broad use of specific antimicrobial classes? J Hosp Infect 2005 0.77
91 The pneumococcus and the mouse protection test: inoculum, dosage and timing. Acta Pathol Microbiol Immunol Scand B 1986 0.77
92 Antibiotic susceptibility of Haemophilus influenzae isolated from cerebrospinal fluid and blood. Acta Pathol Microbiol Immunol Scand B 1986 0.76
93 Attachment of staphylococci to different plastic tubes in vitro. J Med Microbiol 1994 0.76
94 Antibiotic penetration into the infected knee. A rabbit experiment. Acta Orthop Scand 1987 0.76
95 Experimental foreign body infection in mice. J Antimicrob Chemother 1993 0.76
96 Problems with antibiotic resistance in Spain and their relation to antibiotic use in humans elsewhere. Clin Infect Dis 1997 0.75
97 Catheter-related Staphylococcus aureus infections. J Hosp Infect 1993 0.75
98 Novel method to identify the optimal antimicrobial peptide in a combination matrix, using anoplin as an example. Antimicrob Agents Chemother 2013 0.75
99 [Screening for Chlamydia trachomatis?]. Ugeskr Laeger 1997 0.75
100 Control of resistance to sulphonamides. Lancet 2001 0.75
101 Netilmicin treatment of complicated urinary tract infections. Scand J Infect Dis Suppl 1980 0.75
102 Bactericidal effect of penicillin, ampicillin, and amoxicillin alone and in combination with tobramycin against Enterococcus faecalis as determined by kill-kinetic studies. Infection 1991 0.75
103 Animal models in bacteriology. Contrib Microbiol 2001 0.75
104 Nitroimidazoles in the canine prostate, vagina, and urethra. Prostate 1981 0.75
105 [Diagnosis of urinary tract infections and quality of diagnostic methods]. Ugeskr Laeger 1992 0.75
106 Serum concentrations of tobramycin after intraarticular administration. An experimental study in the rabbit. Acta Orthop Scand 1983 0.75
107 [Preventive penicillin therapy in lung surgery. I. A double-blind randomized study]. Ugeskr Laeger 1983 0.75
108 [Treatment of Staphylococcus aureus endocarditis and septicemia]. Ugeskr Laeger 1984 0.75
109 Mecillinam in urinary tract infections and in septicaemia. Infection 1979 0.75
110 Hyponatremia and adrenocortical function in patients with severe bacterial infections. Scand J Infect Dis 1993 0.75
111 [Fluconazole. A new antimycotic for systemic use]. Ugeskr Laeger 1990 0.75
112 Ceftriaxone versus latamoxef in febrile neutropenic patients: empirical monotherapy in patients with solid tumours. Eur J Cancer 1993 0.75
113 [Pleural empyema]. Ugeskr Laeger 1996 0.75
114 Antibiotic prophylaxis in non-cardiac thoracic surgery. A double-blind study of penicillin vs. cefuroxime. Scand J Thorac Cardiovasc Surg 1991 0.75
115 [Anthrax. Description of symptoms, findings, diagnostics and treatment of infection]. Ugeskr Laeger 2001 0.75
116 Antibacterial activity in vitro and regression studies for ceftazidime and ceftriaxone. Acta Pathol Microbiol Immunol Scand B 1985 0.75
117 Fallaxin analogues with improved antibacterial activity. Adv Exp Med Biol 2009 0.75
118 Retrograde contamination and practical handling of urine-meters: a comparison of three systems for the measurement of hourly diuresis in an experimental bladder-drainage model and in clinical use. Br J Urol 1996 0.75
119 [Screening for bacteriuria in the laboratory: autotrak, test strips and microscopic examination compared with culture]. Ugeskr Laeger 1989 0.75
120 In vitro study of the susceptibility of Escherichia coli to mecillinam. J Antimicrob Chemother 2000 0.75
121 [Staphylococcus aureus endocarditis in Denmark 1982-1991. Clinical picture, complications and antibiotic therapy in non-drug addicts]. Ugeskr Laeger 2000 0.75
122 [Therapeutic monitoring of aminoglycoside treatment. The value of early clinical contact]. Ugeskr Laeger 1991 0.75
123 [Treatment of urinary infections with a single dose of antibiotics]. Nord Med 1986 0.75
124 [Nosocomial pneumonia in an intensive care unit]. Ugeskr Laeger 1993 0.75
125 Susceptibility testing with disc diffusion for new cephalosporins: pre-diffusion revisited. Acta Pathol Microbiol Immunol Scand B 1986 0.75
126 [Treatment of urinary infections with a single dose of an antibiotic]. Ugeskr Laeger 1985 0.75
127 [Experience with daily single dose administration of gentamicin]. Ugeskr Laeger 1997 0.75
128 Staphylococcus aureus endocarditis in Denmark 1976-1981. Scand J Infect Dis Suppl 1983 0.75
129 [Chiropractic treatment of infants in the first year of life]. Ugeskr Laeger 1988 0.75
130 Cinoxacin in urinary tract infections. Theoretical and practical considerations. Urology 1981 0.75
131 [Bacteroides fragilis meningitis and bacteremia. Report of a case with otogenic focus and a brief review]. Ugeskr Laeger 1979 0.75
132 [Toxic bone marrow depression after local use of chloramphenicol eye agents]. Ugeskr Laeger 1986 0.75
133 [Asymptomatic bacteriuria during pregnancy]. Ugeskr Laeger 1988 0.75
134 [Preventive antibiotic therapy in lung surgery]. Ugeskr Laeger 1983 0.75
135 [Ciprofloxacin and pivampicillin in acute epididymitis in men above the age of 40 years]. Ugeskr Laeger 2000 0.75
136 Prevalence of and detection of resistance to ampicillin and other beta-lactam antibiotics in Haemophilus influenzae in Denmark. Scand J Infect Dis 2001 0.75
137 [Antibiotic treatment of infections in general practice. Effect of audit assessed by prescriptions data from health insurance registry and physicians' own registration]. Ugeskr Laeger 2001 0.75
138 Detection of penicillin resistance in Streptococcus pneumoniae by diffusion tests. APMIS 1996 0.75
139 Synovectomy for septic arthritis. Early versus late synovectomy studied in the rabbit knee. Acta Orthop Scand 1991 0.75
140 [Preventive penicillin therapy in lung surgery. II Bacteriological study]. Ugeskr Laeger 1983 0.75